Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / GLOBAL EX US HGH
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
6,664,674
-
Shares change
-
+612,615
-
Total reported value, excl. options
-
$142,195,088
-
Value change
-
+$13,033,600
-
Number of buys
-
22
-
Number of sells
-
-38
-
Price
-
$21.37
Significant Holders of INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) as of Q4 2021
73 filings reported holding PGHY - INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH as of Q4 2021.
INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,664,674 shares
.
Largest 10 shareholders include Whitcomb & Hess, Inc. (738,249 shares), JANE STREET GROUP, LLC (737,167 shares), Cerity Partners LLC (465,556 shares), Essex LLC (432,260 shares), CABOT WEALTH MANAGEMENT INC (409,122 shares), PFS INVESTMENTS INC. (338,224 shares), Kestra Advisory Services, LLC (319,406 shares), Legacy Capital Wealth Partners, LLC (279,515 shares), Sowell Financial Services LLC (202,428 shares), and Madrona Financial Services, LLC (197,703 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.